These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22551339)

  • 21. Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.
    Olasupo OO; Lowe MS; Krishan A; Collins P; Iorio A; Matino D
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014201. PubMed ID: 34407214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
    Franchini M; Makris M; Santagostino E; Coppola A; Mannucci PM
    Haemophilia; 2012 May; 18(3):e164-72. PubMed ID: 22250981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemophilia and related bleeding disorders: a story of dismay and success.
    Mannucci PM
    Hematology Am Soc Hematol Educ Program; 2002; ():1-9. PubMed ID: 12446416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure.
    White GC
    Trans Am Clin Climatol Assoc; 2010; 121():61-73; discussion 74-5. PubMed ID: 20697550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophilia: yesterday, today, and tomorrow.
    Aledort LM
    Mt Sinai J Med; 1996; 63(3-4):225-35. PubMed ID: 8692169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2017 Clinical trials update: Innovations in hemophilia therapy.
    Hartmann J; Croteau SE
    Am J Hematol; 2016 Dec; 91(12):1252-1260. PubMed ID: 27563744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [NEW INNOVATIONS IN THE TREATMENT OF HEMOPHILIA].
    Levy-Mendelovich S; Brutman-Barazani T; Kenet G
    Harefuah; 2023 Jan; 162(1):47-51. PubMed ID: 36714942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
    Trinchero A; Sholzberg M; Matino D
    Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemophilia--present and past].
    Terada H
    Nihon Rinsho; 2008 Mar; 66(3):591-9. PubMed ID: 18330030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New perspectives in hemophilia treatment.
    Kessler CM
    Hematology Am Soc Hematol Educ Program; 2005; ():429-35. PubMed ID: 16304415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemophilia B: current pharmacotherapy and future directions.
    Franchini M; Frattini F; Crestani S; Bonfanti C
    Expert Opin Pharmacother; 2012 Oct; 13(14):2053-63. PubMed ID: 22946758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
    Olasupo OO; Noronha N; Lowe MS; Ansel D; Bhatt M; Matino D
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD014544. PubMed ID: 38411279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hemophilias and their clinical management.
    Josephson N
    Hematology Am Soc Hematol Educ Program; 2013; 2013():261-7. PubMed ID: 24319189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment strategies in children with hemophilia.
    Petrini P
    Paediatr Drugs; 2002; 4(7):427-37. PubMed ID: 12083971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Patient Experience of Hemophilia and Human Immunodeficiency Virus: A Systematic Review of Qualitative Evidence.
    Omura K; Tsuchiya S
    JBI Libr Syst Rev; 2012; 10(58):4659-4668. PubMed ID: 27820530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.
    Díaz-Ricart M; Isola IM; Escolar G
    Drugs Today (Barc); 2018 Oct; 54(10):591-600. PubMed ID: 30398480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent improvements in the clinical treatment of coagulation factor inhibitors.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood products for hemophilia: past, present and future.
    Giangrande PL
    BioDrugs; 2004; 18(4):225-34. PubMed ID: 15244500
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.